No insider purchases or sales are on record for Estrella Immunopharma, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-05.
Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2024-06 | 2024-01 | |
|---|---|---|---|---|
| OPERATING INCOME | $-13.1M | — | $-7.3M | — |
| NET INCOME | $-13.1M | — | $-7.3M | — |
| EPS (DILUTED) | -0.35 | — | -0.27 | — |
| OPERATING CASH FLOW | $-1.8M | — | $-16.1M | — |
| CASH | $1.4M | $916.9K | $4.2M | — |
| BUYBACKS | — | — | — | $1.0M |
No password to create and no card required. We store your email address and nothing else.